Genmab A GMAB
NASDAQ GMAB
$39.57 +0.50 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genmab A (GMAB) EV to FCF (2025 - 2026)

Updated

Genmab A's (GMAB) EV to FCF stood at 0.21 in the quarter ended Jun 30, 2026, up 53.3% from the prior quarter.

Analysis

Genmab A (GMAB) EV to FCF (2025 - 2026) Analysis & Trends

On a TTM basis, Genmab A's EV to FCF came in at -2.85 as of Jun 30, 2026; for the year ended Dec 31, 2025, it was 0.23, down 70.0% from the prior year.

  • Annual EV to FCF has declined for three straight years.
  • Across earlier years, EV to FCF came in at 0.76 in the year ended Dec 31, 2024 (-38.6%), 1.24 in the year ended Dec 31, 2023 (-36.3%), 1.95 in the year ended Dec 31, 2022 (+26.2%) and 1.55 in the year ended Dec 31, 2021 (+48.5%).
  • Quarterly EV to FCF has ranged from -0.86 in the quarter ended Jun 30, 2025 to 0.62 in the quarter ended Sep 30, 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Genmab A 2.56 Bn -2.81 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.30
Mar 31, 2026 0.18
Sep 30, 2025 1.04
API Access

Genmab A EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=GMAB&period=max&api_key=YOUR_API_KEY